Trial Profile

A Multicenter Clinical Evaluation of Safety and Efficacy of Lumason as a Contrast Agent in Pediatric Echocardiography

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 15 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sulfur hexafluoride (Primary)
Indications Congenital heart defects; Heart disorders
Focus Diagnostic use
Sponsors Bracco Diagnostics

Most Recent Events

15 Aug 2018 Status changed from recruiting to discontinued.
20 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
18 May 2015 Planned initiation date changed from 1 Mar 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com